Adult and pediatric patients who received 2023-2024 influenza vaccines exhibited reduced risk for influenza-associated encounters across care settings.

Mepolizumab reduces asthma exacerbations among real-world patients with severe asthma and an eosinophilic phenotype.

Researchers at Yale University in a small, yet to be published study found that Covid vaccines were linked to a rare ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...